SCHEMBL4924170

SCHEMBL4924170

CCCN1Cc2nc3c(-c4ccc(OC)c(OC)c4)cccc3c(N)c2C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.42
▸ PIK3CG P48736 1/20 0.39
▸ PDE4B Q07343 2/20 0.38
▸ MAPK1 P28482 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ PDE5A O76074 1/20 0.38
▸ LMNA P02545 2/20 0.36
▸ PARP1 P09874 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ PARP2 Q9UGN5 1/20 0.36
▸ PDE4A P27815 1/20 0.36
▸ PDE4C Q08493 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HPGDS O60760 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ HPGD P15428 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2656333 0.93 PDE5A (0.44) PIK3CGMAPK1KDM4EPDE5ALMNA
SCHEMBL4923490 0.91 KDM4E (0.38) TP53KDM4EPDE5ALMNAMAPT
SCHEMBL2661560 0.88 BRD4 (0.40) KDM4EMAPTALDH1A1KMT2AHRH4
SCHEMBL4923143 0.88 ALDH1A1 (0.39) PIK3CGPDE4BMAPK1KDM4EPDE4A
SCHEMBL4920722 0.87 KDM4E (0.43) TP53KDM4EPDE5ALMNAPARP1
SCHEMBL2661536 0.86 GABRG2 (0.49) TP53PDE5AMAPTALDH1A1GAA
SCHEMBL2661856 0.86 GABRG2 (0.38) TP53PIK3CGPDE5AMAPTALDH1A1
SCHEMBL2661358 0.86 PDE5A (0.40) PIK3CGPDE4BKDM4EPDE5APDE4A
SCHEMBL4926862 0.85 PDE5A (0.41) TP53KDM4EPDE5ALMNAMAPT
SCHEMBL4916122 0.85 GABRG2 (0.39) TP53KDM4EPDE5AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US claimed
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318943-A1 Compounds and Uses Thereof - 848 COMT, BACE1, BDNF TP53 1103/4885PIK3CG 3774/4885PDE4B 715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback